Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.
US FDA says lowest dose of Novo Nordisk's weight-loss drug now available
The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday. Several doses of Novo's GLP-1 therapies such as Wegovy and diabetes drug Ozempic,
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage at various times.
Novo’s main Ozempic plant cited for quality lapses by FDA
Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.
Targeted Oncology
1h
FDA Issues Warning on BioZorb Markers After Recall Due to Patient Complications
Providers advised to halt use, monitor patients, and report any complications with BioZorb devices to the FDA.
3h
FDA expands recall of Dynacare baby powder, sent to IL, IN, WI, due to possible asbestos risk
The Food and Drug administration has expanded a recall of Dynacare baby powder, made by the Dynarex Corporation. The recall ...
BioWorld
6m
BioFuture 2024: FDA eases the way for cell and gene therapy companies
Cell and gene therapy companies are the beneficiaries of positive changes along the regulatory path that the U.S. FDA is paving for them, according to a panel of executives who spoke at the BioFuture ...
1h
on MSN
FDA-approved procedure helps regrow knee cartilage, easing pain
Dr. Rick Lehman performs the MACI procedure, which uses the patient's own cells to regrow cartilage in the knee, eliminating ...
Scripps News on MSN
1h
Recall expanded for baby powder that may contain asbestos, FDA says
A recall issued last month for Dynacare brand baby powder over concerns of asbestos contamination has been expanded, the Food ...
3h
on MSN
Hims & Hers stock falls 14% after FDA changes semaglutide supply status (update)
Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...
oncnursingnews
2h
October 2024 FDA Approvals for Oncology
October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...
Managed Healthcare Executive
1h
FDA Accepts Organon’s Application for Prolia Biosimilar
Regulators are also reviewing Teva’s application for its Prolia biosimilar candidate. The FDA’s decisions are expected ...
Cure Today
2h
CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset
Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
California
Food and Drug Administration
Novo Nordisk
McDonald's
Ozempic
Feedback